Captain obvious. If you look at the countries that allow mc the collective population is 260 million! And this is only growing. So the market is huge and is present.
How can mxc compete with larger companies, because they have a superior product. They control cultivation, extraction and production of the cbd in GMP facilities! Their facilities are located in Europe a clear advantage.
Further to this how do you stay ahead of competition, research. They have partnerships with leading universities including a world first cannabis library.
Where is mxc getting the money to do the projects? Well cannepil they were so smart to link with epilepsy Australia which requires very little marketing and a ready made marketplace! They have created partnerships with companies like cult beauty to market and sell the beauty products. And varm Cosmo deal if it goes ahead is another example of low outlay for high returns. Of course they have hardly any revenue, the reports look back while the deals have happened recently.
So the Malta deal comes around with the potential to access that 260 million and growing population and the company does a cash raise to ensure funds and generate revenue. They are then criticised.... it amazes me that people are not connecting the dots! But each to their own.
MXC Price at posting:
7.5¢ Sentiment: Buy Disclosure: Held
